TAK - Hutchmed upgraded at Deutsche Bank; cancer drug approval cited
2023-11-24 08:54:00 ET
More on Hutchison China MediTech
- Hutchmed: Progressing, But We Would Like More Clarity On Profit Margins
- Takeda wins FDA nod for colorectal cancer therapy
- Seeking Alpha’s Quant Rating on Hutchison China MediTech
- Historical earnings data for Hutchison China MediTech
- Financial information for Hutchison China MediTech
For further details see:
Hutchmed upgraded at Deutsche Bank; cancer drug approval cited